Recombinant Mouse Transmembrane protein 176B (Tmem176b)

What is the molecular structure and function of Tmem176b?

Tmem176b is an intracellular, acid-sensitive, non-specific cation channel that belongs to the membrane-spanning 4A (MS4A) protein family. It shares approximately 30% identity with TMEM176A, another member of the MS4A family . Functionally, Tmem176b serves as an ion channel predominantly localized in endophagosomal membranes where pH is tightly regulated .

The protein is encoded by the Tmem176b gene (also known as Clast1, Lr8, or 1810009M01Rik), which produces multiple transcript variants. Transcript variant 3 (NM_001164209) has been well-characterized and is available as a Myc-DDK-tagged expression-ready ORF plasmid for research applications .

Methodology for structural studies: To investigate Tmem176b structure, researchers typically employ:

• Protein crystallography or cryo-electron microscopy

• Computational modeling based on homology with other MS4A family members

• Electrophysiological characterization to analyze channel properties

What are the expression patterns of Tmem176b in mouse tissues?

Tmem176b exhibits widespread expression across multiple mouse tissues, with particularly high levels detected in:

Methodology for expression analysis:

• Quantitative RT-PCR for transcript quantification

• Immunohistochemistry or immunofluorescence for tissue localization

• Single-cell RNA sequencing for cell-specific expression profiles

• Flow cytometry with validated antibodies for protein quantification

How does Tmem176b function in the immune system?

Tmem176b has emerged as a dual regulator of immune responses, with context-dependent effects that can either promote or inhibit immunity . This duality makes it a particularly interesting target for immunotherapeutic approaches.

Methodology for functional analysis:

• Knockout and overexpression models to assess cellular phenotypes

• Dendritic cell maturation assays measuring surface markers (MHC-II, CD40, CD80, CD86)

• Mixed lymphocyte reaction assays to measure T cell stimulatory capacity

• In vivo disease models (cancer, autoimmunity, transplantation)

How does Tmem176b contribute to cancer progression?

Recent research has uncovered important roles for Tmem176b in promoting cancer development and progression, particularly in lung adenocarcinoma .

Methodology for cancer research:

• Stable cell lines with Tmem176b overexpression or knockdown

• Migration and invasion assays to assess metastatic potential

• EMT marker analysis (E-cadherin, N-cadherin, Vimentin, Snail)

• Phosphorylation status of FGFR1/JNK pathway components by Western blotting

• Orthotopic xenograft models to evaluate tumor growth and metastasis in vivo

• Co-immunoprecipitation to identify signaling pathway interactions

What approaches can be used to model Tmem176b function in experimental systems?

Methodology for genetic manipulation:

• Gene editing with precise CRISPR-Cas9 targeting

• Inducible expression systems for temporal control

• Validation by quantitative RT-PCR and Western blotting

• Functional verification of channel activity alterations

How can researchers investigate the role of Tmem176b in dendritic cell biology?

Tmem176b plays a critical role in dendritic cell (DC) maturation and function, with complex effects depending on the experimental context .

Methodology for DC research:

• Differentiation of bone marrow-derived DCs or monocyte-derived DCs

• Stimulation with various maturation stimuli (LPS, poly I:C, CD40L)

• Flow cytometric analysis of maturation markers

• Mixed lymphocyte reactions to measure T cell stimulatory capacity

• Cytokine secretion profiling by ELISA or multiplex assays

What is the relationship between Tmem176b and the epithelial-mesenchymal transition (EMT) in cancer?

The role of Tmem176b in promoting EMT, particularly in lung adenocarcinoma, represents an emerging area of research with important implications for understanding cancer metastasis .

Methodology for EMT research:

• Wound healing and transwell migration/invasion assays

• Immunoblotting for EMT markers (E-cadherin, Vimentin, Snail)

• Pathway inhibition studies using FGFR and JNK inhibitors

• Tube formation assays with endothelial cells

• Xenograft models with Tmem176b-modified cancer cells

How does the genetic variation in Tmem176b affect its function in different disease contexts?

Several genetic variants of Tmem176b have been identified with potential disease relevance :

Methodology for genetic studies:

• Targeted sequencing or genotyping assays

• Structure-function analysis of variant proteins

• Electrophysiological comparison of wild-type and variant channels

• Population genetics approaches to assess variant frequencies

• Clinical correlation studies in patient cohorts

How can researchers differentiate between Tmem176b and Tmem176a functions?

Given the 30% sequence identity between Tmem176b and Tmem176a, distinguishing their specific functions requires careful experimental design :

Methodology for isoform specificity:

• Western blotting with validated antibodies

• qPCR with primers targeting divergent regions

• Rescue experiments in knockout backgrounds

• Comparative expression profiling across tissues

What are the optimal approaches for studying Tmem176b in the FGFR/JNK signaling pathway?

The involvement of Tmem176b in the FGFR/JNK signaling pathway, particularly in cancer contexts, requires specialized technical approaches :

Methodology for signaling pathway analysis:

• Western blotting for phosphorylated FGFR1, JNK, and Vimentin

• Inhibitor studies using titrated concentrations of pathway blockers

• Co-immunoprecipitation followed by mass spectrometry

• Reporter gene assays for pathway activation

How should researchers interpret contradictory findings regarding Tmem176b function?

The dual and context-dependent roles of Tmem176b can lead to apparently contradictory experimental results. Resolving these contradictions requires careful consideration of:

Methodology for resolving contradictions:

• Parallel experiments in multiple model systems

• Careful attention to experimental conditions

• Comprehensive phenotyping in knockout models

• Integration of in vitro and in vivo findings